BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grisanti LA, Schumacher SM, Tilley DG, Koch WJ. Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease. JACC Basic Transl Sci 2018;3:550-62. [PMID: 30175279 DOI: 10.1016/j.jacbts.2017.12.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferrantini C, Coppini R, Sacconi L. Cardiomyocyte-specific Gq signalling and arrhythmias: novel insights from DREADD technology. Cardiovascular Research 2019;115:992-4. [DOI: 10.1093/cvr/cvz052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rodriguez-Serrano M, Rueda J, Buendía F, Monto F, Aguero J, Osa A, Cano O, Martínez-Dolz L, D'Ocon P. β2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation. Front Pharmacol 2019;10:93. [PMID: 30837872 DOI: 10.3389/fphar.2019.00093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Du X. Sympatho-adrenergic mechanisms in heart failure: new insights into pathophysiology. Medical Review 2021;1:47-77. [DOI: 10.1515/mr-2021-0007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nayak TK, Tilley DG. Recent Advances in GPCR-Regulated Leukocyte Responses during Acute Cardiac Injury. Curr Opin Physiol 2021;19:55-61. [PMID: 33244505 DOI: 10.1016/j.cophys.2020.09.007] [Reference Citation Analysis]
5 Lee C, Viswanathan G, Choi I, Jassal C, Kohlmann T, Rajagopal S. Beta-Arrestins and Receptor Signaling in the Vascular Endothelium. Biomolecules 2020;11:E9. [PMID: 33374806 DOI: 10.3390/biom11010009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bond RA, Lucero Garcia-Rojas EY, Hegde A, Walker JKL. Therapeutic Potential of Targeting ß-Arrestin. Front Pharmacol 2019;10:124. [PMID: 30894814 DOI: 10.3389/fphar.2019.00124] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
7 Zhang X, Reinsmoen NL. Angiotensin II type I receptor antibodies in thoracic transplantation. Human Immunology 2019;80:579-82. [DOI: 10.1016/j.humimm.2019.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Takahashi T, Huang Y, Yamamoto K, Hamano G, Kakino A, Kang F, Imaizumi Y, Takeshita H, Nozato Y, Nozato S, Yokoyama S, Nagasawa M, Kawai T, Takeda M, Fujimoto T, Hongyo K, Nakagami F, Akasaka H, Takami Y, Takeya Y, Sugimoto K, Gaisano HY, Sawamura T, Rakugi H. The endocytosis of oxidized LDL via the activation of the angiotensin II type 1 receptor. iScience 2021;24:102076. [PMID: 33659870 DOI: 10.1016/j.isci.2021.102076] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Li Y, Shi J, Yang J, Ge S, Zhang J, Jia R, Fan X. Uveal melanoma: progress in molecular biology and therapeutics. Ther Adv Med Oncol. 2020;12:1758835920965852. [PMID: 33149769 DOI: 10.1177/1758835920965852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Ali DC, Naveed M, Gordon A, Majeed F, Saeed M, Ogbuke MI, Atif M, Zubair HM, Changxing L. β-Adrenergic receptor, an essential target in cardiovascular diseases. Heart Fail Rev 2020;25:343-54. [PMID: 31407140 DOI: 10.1007/s10741-019-09825-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
11 Kayki-Mutlu G, Koch WJ. Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and β-Arrestins as Targets. Int J Mol Sci 2021;22:E521. [PMID: 33430208 DOI: 10.3390/ijms22020521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Okyere AD, Song J, Patwa V, Carter RL, Enjamuri N, Lucchese AM, Ibetti J, de Lucia C, Schumacher SM, Koch WJ, Cheung JY, Benovic JL, Tilley DG. Pepducin ICL1-9-Mediated β2-Adrenergic Receptor-Dependent Cardiomyocyte Contractility Occurs in a Gi Protein/ROCK/PKD-Sensitive Manner. Cardiovasc Drugs Ther 2022. [PMID: 34997361 DOI: 10.1007/s10557-021-07299-4] [Reference Citation Analysis]
13 Kadam PS, Mueller SC, Ji H, Liu J, Pai AV, Ma J, Speth RC, Sandberg K. Modulation of the rat angiotensin type 1a receptor by an upstream short open reading frame. Peptides 2021;140:170529. [PMID: 33744369 DOI: 10.1016/j.peptides.2021.170529] [Reference Citation Analysis]
14 Guitart-Mampel M, Urquiza P, Borges JI, Lymperopoulos A, Solesio ME. Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function. Cells 2021;10:1552. [PMID: 34205363 DOI: 10.3390/cells10061552] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
15 Johnson AE, Hanley-Yanez K, Yancy CW, Taylor AL, Feldman AM, McNamara DM. Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT. J Card Fail 2019;25:553-60. [PMID: 30978507 DOI: 10.1016/j.cardfail.2019.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Okyere AD, Tilley DG. Self-made allostery: endogenous COMP antagonizes pathologic AT1AR signaling. Cell Res 2021;31:730-1. [PMID: 33737692 DOI: 10.1038/s41422-021-00493-x] [Reference Citation Analysis]